Gene expression profile of omental adipose tissue in human obesity.
The aim of the present study was to gain insight into the pathophysiology of obesity by comparing the pattern of gene expression of omental adipose tissue of obese and lean volunteers using DNA microarrays. Omental adipose tissue biopsies were obtained by laparoscopic surgery from six male patients (44.2+/-6.3 yr). RNA was extracted and pooled for the obese (BMI: 37.3+/-2.5 kg/m2) and lean (BMI: 23.4+/-0.8 kg/m2) groups. From the total number of genes analyzed (1,152 well-characterized human genes), 41% were expressed at sufficient levels in human adipose tissue for detection in the microarray experiments, finding that 89 genes were up-regulated while 64 were down-regulated at least twofold in the omental adipose tissue obtained from obese patients. We found a general tendency to blunt lipolysis inducer genes and a global down-regulation of genes encoding growth factors. Moreover, an up-regulation in the expression of several mitogen-activated protein kinases (MAPKs) was observed. The down-regulation of genes involved in lipolysis activation may be involved in the etiopathogenesis of obesity. In addition, down-regulation of growth factors and the up-regulation of MAPKs may indicate an attempt to restrain adipocyte proliferation and differentiation. Furthermore, obesity is accompanied by an altered expression in omental adipose tissue of genes involved not only in energy homeostasis but also in quite diverse biological functions, such as immune response. The genomic approach underlines the importance of adipose tissue beyond energy metabolism.
Gómez-Ambrosi
Javier
J
Metabolic Research Laboratory, Clínica Universitaria de Navarra, 31008 Pamplona, Spain.
Catalán
Victoria
V
Diez-Caballero
Alberto
A
Martinez-Cruz
L Alfonso
LA
Gil
María J
MJ
García-Foncillas
Jesús
J
Cienfuegos
Javier A
JA
Salvador
Javier
J
Mato
José M
JM
Frühbeck
Gema
G
D000273:Adipose Tissue / Q000276:immunology / Q000378:metabolism*; D002874:Chromosome Mapping; D020869:Gene Expression Profiling; D005786:Gene Expression Regulation; D006133:Growth Substances / Q000096:biosynthesis / Q000235:genetics; D006801:Humans; D053614:Janus Kinase 2; D008066:Lipolysis; D020928:Mitogen-Activated Protein Kinases / Q000235:genetics / Q000378:metabolism; D009765:Obesity / Q000235:genetics* / Q000276:immunology / Q000378:metabolism; D009852:Omentum / Q000033:anatomy & histology*; D011505:Protein-Tyrosine Kinases / Q000096:biosynthesis / Q000235:genetics; D011518:Proto-Oncogene Proteins; D012333:RNA, Messenger / Q000378:metabolism*
D006133:Growth Substances; D011518:Proto-Oncogene Proteins; D012333:RNA, Messenger; D011505:Protein-Tyrosine Kinases; C507924:JAK2 protein, human; D053614:Janus Kinase 2; D020928:Mitogen-Activated Protein Kinases